Key result
μ-agatoxin-Aa1a improves cardiomyocyte adaptation to ischemia-reperfusion injury in preclinical models.
Why the study?
Sodium overload via ion channels is a key mechanism in myocardial ischemia/reperfusion injury, and peptide toxins targeting these channels may offer cytoprotection.
Does mu-agatoxin-Aa1a reduce ischemia/reperfusion injury in cellular and rat models?
Does mu-agatoxin-Aa1a reduce ischemia/reperfusion injury in cellular and rat models?
The peptide toxin mu-agatoxin-Aa1a shows potential as a cytoprotective agent to enhance cardiomyocyte adaptation during myocardial ischemia-reperfusion injury in experimental models.
Answers are grounded in this paper and cite their sources.
mu-agatoxin-Aa1a cytoprotection remains preclinical only; leaves open translation of sodium channel modulation to human ischemia-reperfusion injury.
Myocardial infarction is one of the common cardiovascular diseases. Sodium overload in the myocardium is another of the most important mechanisms underlying ischemia/reperfusion injury. Na+ entry into the cell through ion channels can be controlled using peptide toxins targeting ion channels. In our work, we analyze the use of mu-agatoxin-Aa1a, as a sodium channel modulator, as a cytoprotective agent in ischemia/reperfusion injury. For IRI modeling in vitro, the H9C2 culture was placed under oxygen-glucose deprivation conditions followed by reperfusion. Cell death and ion dynamics were recorded using a fluorescent plate reader. Reversible myocardial ischemia of rats in vivo was created by applying an occluder under the main branch of the left coronary artery. Histological and biochemical changes were recorded. The study demonstrated the ability of mu-agatoxin-Aa1a myocardial cells to adapt to rapidly changing extracellular conditions upon restoration of normal blood flow after a period of ischemia. Thus, the study allows us to consider mu-agatoxin-Aa1a as a biologically active molecule with a targeted effect to enhance the adaptation of cardiomyocytes to OGD/reperfusion conditions.
No takes yet. Share an insight, caveat, or question.
Iurova et al. (2026) studied Myocardial ischemia-reperfusion injury. μ-Agatoxin-Aa1a was evaluated on Cell death, ion dynamics, and histological/biochemical changes. Treatment with μ-agatoxin-Aa1a enhanced the adaptation of cardiomyocytes to oxygen-glucose deprivation and reperfusion conditions in cellular and rat models of ischemia-reperfusion injury.
Synapse has enriched 10 related papers. Consider them for comparative context: